Immunologically, IBD is characterized by an abnormal immune response where the body’s immune system attacks the intestinal mucosa, and thereby elevated levels of pro-inflammatory cytokines such al TNF-α, interleukin (IL)-1, and IL-6 are observed in patients with IBD. This evidence concerns the gene IL6 and inflammatory bowel disease.